Review
Nov 2026
Circulating Tumour DNA (ctDNA) as an Emerging Biomarker of Response in Early-Phase Oncology Drug Development: A Systematic Review.
N. Harel, A. Hamilton, T. Cope et al.
· Targeted oncology · 0 citations